DM: SOKARY Mobile Application With Type II Diabetes
Sponsor
Magda Bayoumi (Other)
Overall Status
Completed
CT.gov ID
NCT04843592
Collaborator
(none)
150
1
9
16.7
Study Details
Study Description
Brief Summary
Android mobile application named (SOKARY)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Android mobile application named (SOKARY) which means diabetes was selected as an example of mobile health application as it has the advantage of Arabic interface, free use it allows users to record his/their blood glucose level, nutrition and physical activity, then provide the user with statistics for those readings. The application also sends notifications to the users such as medication reminders and healthy lifestyle advice.
Study Design
Study Type:
Observational
Actual Enrollment
:
150 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Effectiveness of Using SOKARY Mobile Application on Compliance of Patient With Type II Diabetes: A Quasi- Experimental Study
Actual Study Start Date
:
Aug 30, 2019
Actual Primary Completion Date
:
Dec 15, 2019
Actual Study Completion Date
:
May 30, 2020
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Type II diabetes using mobile app |
Device: SOKARY Mobile
Effectiveness of using SOKARY Mobile Application on compliance of patient with Type II diabetes
|
Outcome Measures
Primary Outcome Measures
- the patient's compliance after using SOKARY mobile app [3 months]
Increase level of Patients' compliance
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Be familiar with the use of mobile health applications.
-
Own a smartphone with an android operating system.
-
Able to use the internet either through Wi-Fi network and\or mobile data.
Exclusion Criteria:
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cairo University | Cairo | Egypt |
Sponsors and Collaborators
- Magda Bayoumi
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Magda Bayoumi,
Lecturer,
Beni-Suef University
ClinicalTrials.gov Identifier:
NCT04843592
Other Study ID Numbers:
- EC10082019
First Posted:
Apr 13, 2021
Last Update Posted:
Apr 13, 2021
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Magda Bayoumi,
Lecturer,
Beni-Suef University
Additional relevant MeSH terms: